Design of tumour-activated oligopeptide prodrugs that exploit the proteolytic activity of matrix metalloproteinases
- 30 November 2002
- journal article
- abstracts
- Published by Elsevier in European Journal Of Cancer
- Vol. 38, S121
- https://doi.org/10.1016/s0959-8049(02)81053-x
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: